Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Cidara Therapeutics Inc (NASDAQ: CDTX) was $48.3 for the day, down -0.98% from the previous closing price of $48.78. In other words, the price has decreased by -$0.98 from its previous closing price. On the day, 0.76 million shares were traded. CDTX stock price reached its highest trading level at $48.5154 during the session, while it also had its lowest trading level at $45.5897.
Ratios:
Our analysis of CDTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 3.87. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 12, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $46.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 26 ’25 when RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares for $44.00 per share. The transaction valued at 99,999,988 led to the insider holds 3,365,523 shares of the business.
Mineo Chrysa bought 2,270 shares of CDTX for $49,281 on Jun 02 ’25. The Director now owns 2,270 shares after completing the transaction at $21.71 per share. On Jun 03 ’25, another insider, Mineo Chrysa, who serves as the Director of the company, bought 1,050 shares for $23.44 each. As a result, the insider paid 24,614 and bolstered with 3,320 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDTX now has a Market Capitalization of 1010648512 and an Enterprise Value of 466283072. For the stock, the TTM Price-to-Sale (P/S) ratio is 3560.93 while its Price-to-Book (P/B) ratio in mrq is 4.16. Its current Enterprise Value per Revenue stands at 1543.984 whereas that against EBITDA is -4.326.
Stock Price History:
The Beta on a monthly basis for CDTX is 1.17, which has changed by 3.1908894 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, CDTX has reached a high of $56.83, while it has fallen to a 52-week low of $10.14. The 50-Day Moving Average of the stock is 74.48%, while the 200-Day Moving Average is calculated to be 131.79%.
Shares Statistics:
CDTX traded an average of 524.83K shares per day over the past three months and 2389640 shares per day over the past ten days. A total of 22.12M shares are outstanding, with a floating share count of 13.09M. Insiders hold about 40.83% of the company’s shares, while institutions hold 47.21% stake in the company. Shares short for CDTX as of 1749772800 were 648282 with a Short Ratio of 1.24, compared to 1747267200 on 445327. Therefore, it implies a Short% of Shares Outstanding of 648282 and a Short% of Float of 5.0100001999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
